Annual Total Expenses
$393.94 M
+$108.53 M+38.03%
December 31, 2023
Summary
- As of February 12, 2025, RXRX annual total expenses is $393.94 million, with the most recent change of +$108.53 million (+38.03%) on December 31, 2023.
- During the last 3 years, RXRX annual total expenses has risen by +$305.91 million (+347.51%).
- RXRX annual total expenses is now at all-time high.
Performance
RXRX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$124.44 M
+$9.49 M+8.26%
September 30, 2024
Summary
- As of February 12, 2025, RXRX quarterly total expenses is $124.44 million, with the most recent change of +$9.49 million (+8.26%) on September 30, 2024.
- Over the past year, RXRX quarterly total expenses has increased by +$14.61 million (+13.30%).
- RXRX quarterly total expenses is now at all-time high.
Performance
RXRX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
RXRX Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +38.0% | +13.3% |
| 3 y3 years | +347.5% | +66.7% |
| 5 y5 years | +514.1% | +66.7% |
RXRX Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +104.3% | at high | +103.1% |
| 5 y | 5-year | at high | +514.1% | at high | +583.1% |
| alltime | all time | at high | +514.1% | at high | +583.1% |
Recursion Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $124.44 M(+8.3%) |
| Jun 2024 | - | $114.95 M(+4.7%) |
| Mar 2024 | - | $109.83 M(+0.3%) |
| Dec 2023 | $393.94 M(+38.0%) | $109.55 M(-0.1%) |
| Sep 2023 | - | $109.65 M(+18.2%) |
| Jun 2023 | - | $92.73 M(+13.1%) |
| Mar 2023 | - | $82.00 M(+9.8%) |
| Dec 2022 | $285.41 M | $74.66 M(-1.3%) |
| Sep 2022 | - | $75.63 M(+2.4%) |
| Jun 2022 | - | $73.84 M(+20.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $61.28 M(-9.2%) |
| Dec 2021 | $192.78 M(+119.0%) | $67.46 M(+37.9%) |
| Sep 2021 | - | $48.90 M(+12.6%) |
| Jun 2021 | - | $43.43 M(+31.7%) |
| Mar 2021 | - | $32.98 M(+17.2%) |
| Dec 2020 | $88.03 M(+37.2%) | - |
| Dec 2020 | - | $28.13 M(+20.6%) |
| Sep 2020 | - | $23.34 M(+28.1%) |
| Jun 2020 | - | $18.22 M(-0.7%) |
| Mar 2020 | - | $18.34 M |
| Dec 2019 | $64.15 M | - |
FAQ
- What is Recursion Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual total expenses year-on-year change?
- What is Recursion Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly total expenses year-on-year change?
What is Recursion Pharmaceuticals annual total expenses?
The current annual total expenses of RXRX is $393.94 M
What is the all time high annual total expenses for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual total expenses is $393.94 M
What is Recursion Pharmaceuticals annual total expenses year-on-year change?
Over the past year, RXRX annual total expenses has changed by +$108.53 M (+38.03%)
What is Recursion Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of RXRX is $124.44 M
What is the all time high quarterly total expenses for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly total expenses is $124.44 M
What is Recursion Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, RXRX quarterly total expenses has changed by +$14.61 M (+13.30%)